NGF Gene

Migration, Crosslink

📖

NGF Gene

active

wiki page Created: 2026-04-02T07:19:21 By: crosslink-migration Quality: 50% ✓ SciDEX ID: wiki-genes-ngf

📖 Wiki Page

gene1538 wordssynced 2026-04-02

NGF Gene

<table class="infobox infobox-gene">
<tr>
<th class="infobox-header" colspan="2">NGF</th>
</tr>
<tr>
<td class="label">Full Name</td>
<td>Nerve Growth Factor</td>
</tr>
<tr>
<td class="label">Chromosome</td>
<td>1p13.1</td>
</tr>
<tr>
<td class="label">Gene Type</td>
<td>Protein-coding gene</td>
</tr>
<tr>
<td class="label">NCBI Gene ID</td>
<td>4800</td>
</tr>
<tr>
<td class="label">OMIM</td>
<td>162030</td>
</tr>
<tr>
<td class="label">Ensembl ID</td>
<td>ENSG000001116655</td>
</tr>
<tr>
<td class="label">UniProt</td>
<td>P01138</td>
</tr>
<tr>
<td class="label">Protein Family</td>
<td>Neurotrophin family</td>
</tr>
<tr>
<td class="label">Receptors</td>
<td>TrkA (NTRK1), p75NTR (TNFRSF1B)</td>
</tr>
<tr>
<td class="label">Major Pathways</td>
<td>PI3K/Akt, MAPK/ERK, PLCγ</td>
</tr>
<tr>
<td class="label">Primary Disease Links</td>
<td>Alzheimer's Disease, Peripheral Neuropathy</td>
</tr>
<tr>
<td class="label">Associated Diseases</td>
<td><a href="/wiki/als" style="color:#ef9a9a">ALS</a>, <a href="/wiki/alzheimer's-disease" style="color:#ef9a9a">ALZHEIMER'S DISEASE</a>, <a href="/wiki/aging" style="color:#ef9a9a">Aging</a>, <a href="/wiki/als" style="color:#ef9a9a">Als</a>, <a href="/wiki/alzheimer" style="color:#ef9a9a">Alzheimer</a></td>
</tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">247 edges</a></td>
</tr>
</table>

NGF Gene

Pathway Diagram

...

NGF Gene

<table class="infobox infobox-gene">
<tr>
<th class="infobox-header" colspan="2">NGF</th>
</tr>
<tr>
<td class="label">Full Name</td>
<td>Nerve Growth Factor</td>
</tr>
<tr>
<td class="label">Chromosome</td>
<td>1p13.1</td>
</tr>
<tr>
<td class="label">Gene Type</td>
<td>Protein-coding gene</td>
</tr>
<tr>
<td class="label">NCBI Gene ID</td>
<td>4800</td>
</tr>
<tr>
<td class="label">OMIM</td>
<td>162030</td>
</tr>
<tr>
<td class="label">Ensembl ID</td>
<td>ENSG000001116655</td>
</tr>
<tr>
<td class="label">UniProt</td>
<td>P01138</td>
</tr>
<tr>
<td class="label">Protein Family</td>
<td>Neurotrophin family</td>
</tr>
<tr>
<td class="label">Receptors</td>
<td>TrkA (NTRK1), p75NTR (TNFRSF1B)</td>
</tr>
<tr>
<td class="label">Major Pathways</td>
<td>PI3K/Akt, MAPK/ERK, PLCγ</td>
</tr>
<tr>
<td class="label">Primary Disease Links</td>
<td>Alzheimer's Disease, Peripheral Neuropathy</td>
</tr>
<tr>
<td class="label">Associated Diseases</td>
<td><a href="/wiki/als" style="color:#ef9a9a">ALS</a>, <a href="/wiki/alzheimer's-disease" style="color:#ef9a9a">ALZHEIMER'S DISEASE</a>, <a href="/wiki/aging" style="color:#ef9a9a">Aging</a>, <a href="/wiki/als" style="color:#ef9a9a">Als</a>, <a href="/wiki/alzheimer" style="color:#ef9a9a">Alzheimer</a></td>
</tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">247 edges</a></td>
</tr>
</table>

NGF Gene

Pathway Diagram

Mermaid diagram (expand to render)

Introduction

Nerve Growth Factor (NGF) is the founding member of the neurotrophin family of growth factors and was the first growth factor ever characterized. Discovered by Rita Levi-Montalcini and Stanley Cohen in 1956, NGF revolutionized neuroscience by demonstrating that specific molecules could control neuronal survival and differentiation. The discovery earned Levi-Montalcini the Nobel Prize in Physiology or Medicine in 1986, highlighting the fundamental importance of NGF in neurobiology. [@levimontalcini1987]

NGF is essential for the development, survival, and maintenance of specific neuronal populations in the central and peripheral nervous systems. Its role extends beyond development into adulthood, where it continues to support neuronal function and plasticity, particularly in cholinergic basal forebrain neurons that are vulnerable in Alzheimer's disease.

Molecular Biology

Gene Structure

The NGF gene is located on chromosome 1p13.1 and contains multiple exons that allow for regulated expression. The gene structure is conserved across mammalian species, enabling comparative studies of NGF function.

Key features:

Single polypeptide encoding the NGF protein
Multiple transcription start sites for tissue-specific regulation
Conserved regulatory elements in promoter region

Protein Processing

NGF is synthesized as a precursor protein (pro-NGF) that undergoes proteolytic processing:[@lee2001]

Pre-pro-NGF: Initial translation product with signal peptide

Pro-NGF: Partially processed form (~30 kDa)

Can signal through p75NTR to induce apoptosis
Distinct biological activities from mature NGF

3. Mature NGF: Fully processed form (~14 kDa)

120 amino acid homodimer
High-affinity TrkA binding

The processing ratio of pro-NGF to mature NGF is dynamically regulated and varies across:

Cell types
Developmental stages
Physiological conditions
Disease states

Structure-Function Relationship

The NGF protein adopts a fold structure characteristic of neurotrophins:

N-terminal region: Receptor binding specificity
Central core: Dimerization interface
C-terminal domain: TrkA activation interface

NGF forms a homodimer for biological activity, with each monomer capable of binding one TrkA receptor, leading to dimerization and activation.

Receptor Signaling

Dual Receptor System

NGF signals through two distinct receptor classes:[@chao2003]

TrkA (NTRK1) Receptor

TrkA is the high-affinity signaling receptor for NGF:

Expression: Primarily in nociceptive sensory neurons, cholinergic basal forebrain neurons, sympathetic ganglia
Affinity: Kd ~10⁻¹¹ M for NGF
Signaling: Intrinsic tyrosine kinase activity

Receptor activation cascade:

NGF binding induces TrkA dimerization

Autophosphorylation of tyrosine residues

Recruitment of adaptor proteins

Activation of downstream pathways

p75NTR (TNFRSF1B) Receptor

p75NTR is the low-affinity NGF receptor:

Expression: Broad across neuronal populations
Affinity: Kd ~10⁻⁹ M for NGF
Signaling: No intrinsic kinase activity

Functions:

Co-receptor: Enhances TrkA signaling when co-expressed
Mediates apoptosis: Especially during development
Bidirectional: Can promote survival or death depending on context

Signaling Pathways

PI3K/Akt Pathway (Survival)

Activation follows TrkA autophosphorylation
Promotes neuronal survival
Key target: BAD phosphorylation inhibits apoptosis

Ras/MEK/ERK Pathway (Differentiation)

Ras activation recruits Raf/MEK/ERK cascade
Promotes neuronal differentiation
Regulates gene transcription via CREB

PLCγ Pathway (Plasticity)

PLCγ recruitment to phosphorylated TrkA
IP3/DAG production
Calcium release and PKC activation
Modulates synaptic plasticity

Physiological Roles

Development

During embryonic development, NGF is essential for:[@snider1994]

Sensory neuron survival: Supports sympathetic ganglion and sensory neurons

Axonal guidance: NGF gradients direct axon growth

Target innervation: Retrograde signaling maintains neurons

Synapse formation: Influences synaptic connectivity

The requirement for target-derived NGF during development is a classic example of trophic dependence.

Adult Nervous System

In the adult brain, NGF continues to play critical roles:[@mufson2003]

Basal forebrain cholinergic neurons (BFCNs):

Essential for maintenance and function
Project to hippocampus and cortex
Vulnerable in Alzheimer's disease
NGF transport impaired in AD

Synaptic plasticity:

Modulates long-term potentiation (LTP)
Influences memory formation
Activity-dependent regulation

Neuroprotection:

Trophic support against insults
Maintains cholinergic phenotype

Peripheral Nervous System

In the PNS, NGF supports:[@farinas1999]

Nociceptive neurons: Pain sensation

Sympathetic neurons: Autonomic function

Thermoregulation: Central thermoregulatory circuits

Disease Associations

Alzheimer's Disease

NGF has intense focus in AD due to BFCN vulnerability:[@mufson2003]

Pathological changes:

NGF transport impairment in cholinergic neurons
Reduced TrkA expression in AD brain
Altered pro-NGF/mature NGF balance

Therapeutic approaches:

NGF protein delivery
AAV-NGF gene therapy
Small molecule TrkA agonists
Cell-based delivery

Clinical trials:

Intrathecal NGF administration
Gene therapy trials (preclinical)
Ongoing AAV-NGF studies

Peripheral Neuropathies

NGF has shown promise in treating peripheral neuropathies.

Diabetic neuropathy:

NGF administration tested in clinical trials
Protects sensory neurons
May restore nerve function

Chemotherapy-induced neuropathy:

May protect against neuronal damage
Adjunctive therapy potential

Other Conditions

Huntington's Disease:

Supports striatal neuron survival
Gene therapy approaches

Retinitis Pigmentosa:

Protects photoreceptor neurons
Clinical trials with encapsulated cells

Therapeutic Applications

Delivery Challenges

NGF facing significant delivery challenges:

| Challenge | Impact | Solution Approach |
|-----------|--------|----------------|
| Blood-brain barrier | Poor CNS penetration | Direct CNS delivery |
| Side effects | Pain, weight loss | Targeted delivery |
| Short half-life | Frequent dosing | Sustained release systems |
| Receptor tropism | Non-specific effects | Selective targeting |

Clinical Approaches

Recombinant NGF protein:

Intrathecal administration
Limited by side effects
Historical trials (1990s-2000s)

Gene therapy:

AAV-mediated NGF delivery
Long-term expression
Currently in development

Cellular delivery:

Encapsulated cell biodelivery
Controlled release
Clinical trials for eye diseases

TrkA agonists:

Small molecule oral compounds
Bypass protein delivery issues
Preclinical/clinical development

Challenges and Solutions

Pain side effects:

NGF affects nociceptive neurons
Targeted delivery to basal forebrain
Selective TrkA agonists

BBB penetration:

Intrathecal delivery
Convection-enhanced delivery
AAV gene therapy

Dosing:

Continuous vs. pulsed delivery
Encapsulated cell systems
Regulated gene expression

Animal Models

NGF Knockout Mice

Complete NGF knockout is embryonic lethal, similar to BDNF, demonstrating essential developmental roles:

Phenotypic characteristics:

Loss of sensory and sympathetic neurons
Severe deficits in neural development
Perinatal lethality

Conditional knockout models:

Forebrain-specific deletion
Sensory neuron-specific deletion
Inducible models for adult studies

NGF Overexpression Models

Transgenic overexpression:

Enhanced cholinergic function
Increased neuronal survival
Protection in AD models

Viral-mediated delivery:

AAV-NGF to basal forebrain
Rescue of cholinergic deficits
Improvement in memory tasks

Therapeutic Targets

TrkA Agonists

| Compound | Mechanism | Stage | Notes |
|----------|-----------|-------|-------|
| NGFC mimetics | TrkA agonist | Preclinical | Peptide-based |
| Small molecule agonists | TrkA activation | Research | Oral delivery |
| ANA-12 | TrkA antagonist | Research | Used to study NGF role |

NGF Delivery Methods

Recombinant protein

Intrathecal delivery
Intravenous administration
Limited by blood-brain barrier penetration
Historical trials showed side effects

AAV gene therapy

Viral vector delivery
Long-term expression
Targeted CNS delivery
Clinical trials ongoing

Gene therapy

AAV-NGF vectors
Long-term expression
Clinical trials ongoing

Cellular delivery

Encapsulated cells
Controlled release

Small molecules

TrkA agonists
Bypass protein delivery

Genetic Studies

NGF Polymorphisms

Promoter variants affecting expression
Coding variants
5' and 3' regulatory elements
Association with disease risk

GWAS Findings

Alzheimer's disease risk
Peripheral neuropathy susceptibility
Pain perception variants
Cognitive function associations

Cross-Links

[Nerve Growth Factor](/proteins/nerve-growth-factor) — protein information
[TrkA Signaling Pathway](/mechanisms/trka-signaling)
[Neurotrophin Signaling in Neurodegeneration](/mechanisms/neurotrophin-signaling)
[Alzheimer's Disease](/diseases/alzheimers-disease)
[Parkinson's Disease](/diseases/parkinsons-disease)
[Basal Forebrain Cholinergic Neurons](/cell-types/basal-forebrain-cholinergic-neurons)
[Hippocampus](/brain-regions/hippocampus)
[Cortex](/brain-regions/cortex)
[Tau Pathology](/mechanisms/tau-pathology)
[Amyloid-Beta](/proteins/amyloid-beta)

External Links

[NCBI Gene: NGF](https://www.ncbi.nlm.nih.gov/gene/4800)
[UniProt: NGF](https://www.uniprot.org/uniprotkb/P01138/entry)
[Ensembl: NGF](https://www.ensembl.org/Homo_sapiens/Gene/Summary?g=ENSG000001116655)
[OMIM: NGF](https://omim.org/entry/162030)
[Allen Human Brain Atlas: NGF](https://human.brain-map.org/microarray/search/show?search_term=NGF)
[ClinicalTrials.gov: NGF](https://clinicaltrials.gov/search?term=NGF)

References

[Levi-Montalcini R, The nerve growth factor: thirty-five years later (1987)](https://doi.org/10.1126/science.3306916)

[Chao MV, Neurotrophins and their receptors: a convergence point for many signalling pathways (2003)](https://doi.org/10.1038/nrn1078)

[Lee R, Kermani P, Teng KK, Hempstead BL, Regulation of cell survival by secreted proneurotrophins (2001)](https://doi.org/10.1126/science.1064257)

[Mufson EJ, Counts SE, Perez SE, Binder LI, Nerve growth factor in Alzheimer's disease (2003)](https://doi.org/10.1016/j.expneurol.2003.08.015)

[Price RD, Milne SA, Sharkey J, Matsuoka N, Potential of NGF and related neurotrophins (2003)](https://doi.org/10.1038/nrd984)

[Snider WD, Johnson EM, Neuronal survival: the paradox of neurotrophin-mediated signaling (1994)](https://pubmed.ncbi.nlm.nih.gov/7856627/)

[Farinas I, Neurotrophin action on sensory neurons (1999)](https://pubmed.ncbi.nlm.nih.gov/10375574/)

[Heese K, et al, NGF and Alzheimer's disease (1998)](https://pubmed.ncbi.nlm.nih.gov/9708378/)

[Yun JS, et al, NGF signaling in the basal forebrain (1988)](https://pubmed.ncbi.nlm.nih.gov/3054453/)

[Cuello AC, et al, NGF and cholinergic neurons in Alzheimer's disease (1995)](https://pubmed.ncbi.nlm.nih.gov/7642902/)

[Terenius L, et al, NGF in the regulation of sympathetic neurons (1976)](https://pubmed.ncbi.nlm.nih.gov/182800/)

[Drummond JC, et al, NGF receptors in development (1983)](https://pubmed.ncbi.nlm.nih.gov/6319318/)

[Bothwell M, NGF binding to sensory neurons (1982)](https://pubmed.ncbi.nlm.nih.gov/6289231/)

[Greene LA, et al, NGF effects on PC12 cells (1977)](https://pubmed.ncbi.nlm.nih.gov/870407/)

[Rabin JS, et al, NGF and axon growth (1985)](https://pubmed.ncbi.nlm.nih.gov/3923448/)

Pathway Diagram

The following diagram shows the key molecular relationships involving NGF Gene discovered through SciDEX knowledge graph analysis:

Mermaid diagram (expand to render)

📖 View canonical wiki page →

Related Entities

NGF

▸Metadataorigin_type: v1_polymorphic_backfill

slug	genes-ngf
kg_node_id	NGF
entity_type	gene
origin_type	v1_polymorphic_backfill
source_table	wiki_pages
wiki_page_id	wp-40a965b464b9
__merged_from	{'merged_at': '2026-05-13', 'unprefixed_id': 'genes-ngf'}
_schema_version	1

📊 Evidence Profile Foundational

Evidence Balance

+0%

Certainty

80%

Debates

0

Incoming

16

Outgoing

53

0 supporting 0 contradicting 0 neutral

View full evidence profile →

Public annotations (0)Annotate on Hypothes.is →

No public annotations yet.

📗 Cite This Artifact

NGF Gene

NGF Gene

NGF Gene

Pathway Diagram

NGF Gene

NGF Gene

Pathway Diagram

Introduction

Molecular Biology

Gene Structure

Protein Processing

Structure-Function Relationship

Receptor Signaling

Dual Receptor System

TrkA (NTRK1) Receptor

p75NTR (TNFRSF1B) Receptor

Signaling Pathways

PI3K/Akt Pathway (Survival)

Ras/MEK/ERK Pathway (Differentiation)

PLCγ Pathway (Plasticity)

Physiological Roles

Development

Adult Nervous System

Peripheral Nervous System

Disease Associations

Alzheimer's Disease

Peripheral Neuropathies

Other Conditions

Therapeutic Applications

Delivery Challenges

Clinical Approaches

Challenges and Solutions

Animal Models

NGF Knockout Mice

NGF Overexpression Models

Therapeutic Targets

TrkA Agonists

NGF Delivery Methods

Genetic Studies

NGF Polymorphisms

GWAS Findings

Cross-Links

External Links

References

Pathway Diagram

💬 Discussion